MOUNJARO® is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic …
How Mounjaro® Works | Mounjaro® (tirzepatide)
Learn more about how Mounjaro® works as a single-molecule GIP and GLP-1 receptor agonist.
Mounjaro: Para qué sirve, Dosis y Efectos Secundarios
Información para el paciente sobre Mounjaro: para qué sirve, dosis, efectos secundarios y cómo usar este medicamento.
Mounjaro: para qué sirve, cómo usarlo y efectos secundarios
El Mounjaro es un medicamento indicado para el tratamiento de la diabetes tipo 2 no controlada en adultos, pues ayuda a bajar los niveles de azúcar en la sangre, aumentar la saciedad y reducir el …
New Drug: Tirzepatide (Mounjaro ™) - PubMed
Feb 1, 2023 · Tirzepatide (Mounjaro™) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) receptor and GLP-1 receptor agonist. Evidence from five SURPASS clinical trials has …
Mounjaro: o que é, como funciona e para quem é indicado | Ge
Jun 16, 2025 · Disponível nas farmácias brasileiras desde meados de maio, o Mounjaro, da farmacêutica Eli Lilly, é agora mais uma opção disponível para o tratamento de diabetes tipo 2 e de …
Mounjaro - European Medicines Agency (EMA)
Dec 11, 2025 · Mounjaro is a medicine used together with diet and physical activity to treat adults who have type 2 diabetes which is not satisfactorily controlled. It can be used on its own in patients who …